Coming off a robust 2014, corporations kicked up their buying spree again in the first half of 2015, led by deal-hungry health care and pharmaceutical companies and buoyed by cheap financing that has fueled the mergers and acquisitions boom to its highest level in eight years.
The Seventh Circuit on Wednesday refused to increase a $1.8 million penalty imposed on Visteon Corp. in a class action over the auto parts supplier’s failure to notify laid-off employees of important health insurance information in violation of the Employee Retirement Income Security Act, ruling the plaintiffs filed their appeal months too late.
The Seventh Circuit on Wednesday rebuffed Wheaton College’s bid to block the Affordable Care Act’s mandate to provide contraception coverage for its students and employees, ruling the law doesn’t actually require the school to pay for coverage of emergency contraceptives.
A Florida federal judge on Tuesday sentenced five people to a collective 13.5 years in prison for their roles in a $25 million health care fraud scheme that involved recruiting individuals in Nicaragua and the Dominican Republic to enroll in Medicare and Medicaid plans.
The Centers for Medicare & Medicaid Services on Wednesday proposed new exceptions to its controversial requirement for inpatient admissions to cross two midnights and said that audits will be less aggressive, drawing quick praise from hospitals.
CSX Transportation Inc., Amtrak and other rail carriers sued Massachusetts on Wednesday over the state's new paid sick time law, arguing that it shouldn't apply to them because of pre-existing legislation and union contracts.
The state of Texas on Wednesday officially began extending benefits to the spouses of gay and lesbian state workers in the wake of last week's landmark U.S. Supreme Court decision in favor of same-sex marriage, even as Republican politicians including Texas Gov. Greg Abbott decried the decision.
A New Jersey federal judge on Tuesday dismissed antitrust, Employee Retirement Income Security Act and other claims from a class action accusing Aetna Inc. of using rigged price schedules to underpay for out-of-network services, saying those claims weren't strong enough.
China Petroleum & Chemical and Cnooc are among the companies interested in buying stakes in Brazilian oil company Petrobras, Montagu Private Equity moves toward unloading its prescription retail unit Centor in a potential $700 million deal and Interactive Data explores a possible sale or initial public offering that could value it around $5 billion.
A year after the Florida Supreme Court deemed the state's $1 million statutory cap on wrongful death noneconomic damages from medical malpractice unconstitutional, a state appeals court on Wednesday extended that decision to personal injury medical malpractice cases.
A former University of Washington nurse, who claims she was assaulted and wrongfully fired after reporting health and research violations, urged a Washington federal judge Tuesday to sanction a Garvey Schubert Barer attorney for interrupting deposition proceedings with “groundless and scattergun objections” more than 1,000 times.
A Louisiana federal judge on Tuesday refused to recuse herself and subsequently dismissed a racketeering suit accusing President Obama, past U.S. presidents and other officials of, among other things, murdering the plaintiff’s husband and laundering Medicare and Medicaid funds, calling the claims “delusional.”
The former owner of a Chicago hospital must remain in jail awaiting trial on criminal contempt and other charges, an Illinois federal judge ruled Wednesday, deeming the man a flight risk after he spent nearly a decade in Canada in an apparent effort to outrun $188 million in civil judgments tied to a massive health care fraud.
One Texas clerk who originally declined to provide same-sex marriage licenses, with approval from the state attorney general, said Tuesday her office will comply with federal law.
A California district court’s ruling that the U.S. Army doesn’t have to provide medical care for veterans who had volunteered to participate in experiments with chemical and biological weapons was out of line, a panel of Ninth Circuit judges said Tuesday.
Pharmaceutical companies and medical device makers paid $6.49 billion to U.S. doctors and teaching hospitals in 2014, according to data released Tuesday by the federal government as part of its efforts to make health care industry financial data more transparent.
With a projected $1 billion budget surplus and Republicans dominating Tallahassee, Florida's 2015 legislative session held promise for big policy changes. But rifts between the chambers over health care and land conservation forced a special session to pass the budget, pushing gaming and other high-profile issues to the sidelines. Here, Law360 takes a look at key issues left hanging after this year’s historic session.
A spurned contractor on Friday launched a Federal Claims Court challenge to a decision by the U.S. Department of Veterans Affairs and Government Accountability Office not to award it a $127.5 million hospital contract, saying the agencies' choice to reimburse its bid preparation and protest costs is an inadequate remedy.
The government is seeking up to $3.35 billion in a False Claims Act suit accusing Novartis Pharmaceutical Corp. of paying illegal kickbacks to pharmacies to recommend iron-reduction drug Exjade and transplant drug Myfortic, according to filings in New York federal court.
The New Jersey Tax Court has denied three years of property tax exemptions to a nonprofit hospital in a matter of first impression, finding the hospital's large number of private practice doctors and for-profit affiliates precluded it from the tax relief.
Chief Justice John Roberts' dissenting argument in Obergefell v. Hodges misses the point entirely. If the U.S. Supreme Court has any rights at all, such rights surely include the ability to ensure that states don’t create laws — in Obergefell, bans on same-sex marriage — that abridge a citizen’s right to life, liberty and the pursuit of happiness, says Janice Mock of Nossaman LLP.
In high-stakes litigation, the role of data in supporting expert testimony is growing rapidly at a time when there has been an explosion in the number of database platforms and software tools. Given that expert discovery timelines have not expanded to reflect this increased size and complexity, these trends have important implications for required computing resources and expertise, says Mike DeCesaris of Cornerstone Research Inc.
Although former Republican Massachusetts Sen. Scott Brown didn't cast the deciding vote in the U.S. Supreme Court's 5-4 ruling in King v. Burwell, the one-time Cosmopolitan magazine pick for "America's Sexiest Man" played a significant role in the legal trials and tribulations of the Affordable Care Act, says Kim Wilcoxon of Thompson Hine LLP.
With "right to try" measures that provide seriously ill patients access to experimental treatments being drafted in 40 states, drug and biologic developers have faced increasing pressure from patients and their advocates to make investigational drugs available for compassionate use. Vicki Norton of Duane Morris LLP has some advice for navigating the risks associated with allowing patients compassionate use of experimental drugs.
Whether on competition in the solar energy market, oversight of professional occupations or the safety of electronic payment systems, businesses should proactively engage with state attorneys general as they fulfill their consumer protection role, says Foley & Lardner LLP's Joseph Jacquot, a former Florida deputy attorney general and chief of staff of the attorney general’s office.
The Philadelphia Court of Common Pleas' ruling in Baum v. Keystone Mercy Health Plan reinforces the case that a lack of standing is a powerful defense for companies facing data breach-related class actions. Baum also recognizes that lack of standing can be asserted at the certification stage when the purported class representative cannot demonstrate that he or she suffered injury or harm, say attorneys at Pepper Hamilton LLP.
In legal marketing circles, there are few topics peddled about more than “hot tips” for improving your law firm’s website. Google it. You’ll find more advice than you could ever digest. However, there are larger trends in technology, culture and user behavior that are impacting firms in very significant ways and are not being talked about nearly as much as they should be, says Stephan Roussan, founder of consulting and web developm... (continued)
The bottom line of the U.S. Supreme Court's ruling in King v. Burwell is that the Affordable Care Act, as a whole, had a consistent intent for federal tax subsidies to be available to reduce consumer spending on health insurance purchased through federally run exchanges, even if ambiguous provisions and inartful drafting can be found within the statute, say attorneys at Locke Lord LLP.
The recent granting of class certification by the District of New Jersey to participating and nonparticipating chiropractors in DeMaria v. Horizon Healthcare Inc. offers a blueprint to class action certification for health care providers seeking to challenge health insurer policies that may systematically deny or reduce benefits paid, says James Ferrelli of Duane Morris LLP.
With a rapidly increasing and largely inelastic demand resulting from health-conscious and aging populations throughout the world and the relative availability of capital, the life sciences industry is in an enviable position regarding patent growth — especially when compared with other industries competing for revenues, say Kevin Granahan and David Magagna at Fox Rothschild LLP.